Pharmacology Research & Perspectives
- 期刊全稱:Pharmacology Research & Perspectives
- 簡稱:PHARMACOL RES PERSPE
- ISSN:2052-1707
- ESSN:2052-1707
- 研究方向:Pharmacology, Toxicology and Pharmaceutics - General Pharmacology, Toxicology and Pharmaceutics
投稿咨詢
免費咨詢
2023最新分區
Pharmacology Research & Perspectives英文簡介
PR&P is jointly published by the American Society for Pharmacology and Experimental Therapeutics (ASPET), the British Pharmacological Society (BPS), and Wiley. PR&P is a bi-monthly open access journal that publishes a range of article types, including: target validation (preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development); drug discovery reviews (strategy, hypotheses, and data resulting in a successful therapeutic drug); frontiers in translational medicine (drug and target validation for an unmet therapeutic need); pharmacological hypotheses (reviews that are oriented to inform a novel hypothesis); and replication studies (work that refutes key findings [failed replication] and work that validates key findings). PR&P publishes papers submitted directly to the journal and those referred from the journals of ASPET and the BPS
Pharmacology Research & Perspectives中文簡介
《Pharmacology Research & Perspectives》是一本由Wiley-Blackwell出版商出版的專業醫學期刊,該刊創刊于2013年,刊期6 issues/year,該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中,該刊分區信息為大類學科:醫學 4區,小類學科:藥學 4區;在JCR(Journal Citation Reports)分區等級為Q3。該刊發文范圍涵蓋藥學等領域,旨在及時、準確、全面地報道國內外藥學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等,促進學術交流,鼓勵學術創新。2021年影響因子為2.963,平均審稿速度20 Weeks。
中科院分區最新升級版(當前數據版本:2021年12月最新升級版)
大類學科 |
分區 |
小類學科 |
分區 |
Top期刊 |
綜述期刊 |
醫學 |
4區 |
PHARMACOLOGY & PHARMACY
藥學
|
4區
|
否 |
否 |
JCR分區(當前數據版本:2021-2022年最新版)
JCR分區等級 |
JCR所屬學科 |
分區 |
影響因子 |
Q3 |
PHARMACOLOGY & PHARMACY |
Q3 |
2.963 |
期刊指數
影響因子 |
h-index |
Gold OA文章占比 |
研究類文章占比 |
OA開放訪問 |
平均審稿速度 |
2.963 |
-- |
95.58% |
81.38% |
開放 |
20 Weeks |
IF值(影響因子)趨勢圖